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Human chorionic gonadotropin (hCG), labeled with 1251, was
used to study the binding properties of hCG to polystyrene
beads.

The binding capacity of the 0.25-in diameter beads

was determined to be approximately 300 mIU/bead.

The

affinity constant, K, was determined to be essentially 0,
suggesting that binding is strictly passive.

The binding

of hCG to polystyrene was proportional to the hCG concentration and temperature.

There were highly significant

(p<0.001) differences among amounts of hCG bound at 3 C,
25 C and 37 C.

There was a highly significant (p<0.001)

relationship between the amount of hCG bound and the initial
hCG concentration.

There did not appear to be any correla-

tion between the percentage of hCG bound and the initial hCG
concentration.

Attempts to use Staphylococcal Protein

A-peroxidase conjugate to detect murine monoclonal antibodies to beta-hCG were not successful.

viii

INTRODUCTION

Human chorionic gonadotropin (hCG) is a glycoprotein
hormone secreted by trophoblastic tissue.

It is made up

of two polypeptide chains and contains 30-33% carbohydrate,
mainly sialic acid and galactose.

The alpha subunits of the

four human glycoprotein hormones, luteinizing hormone, (hLH),
follicle stimulating hormone (hFSH), thyroid stimulating
hormone (hTSH), and hCG are almost identical, and the beta
subunit of hCG has a high degree of homology with the beta
subunit of hLH.
Since hCG is normally produced by trophoblastic tissue,
its detection has long been used for the determination of
pregnancy.

In normal pregnancy hCG is detectable in the

serum and urine 8-10 d after conception and reaches peak
levels during the second and third gestational month.

By

exerting a luteotrophic effect, hCG maintains the developing
corpus luteum until the placenta starts to produce progesterone, the latter occurring approximately 8-10 wk after
conception.

Kreig (1979) and Levitt and Josimovich (1976)

have reviewed the use of hCG assays in pregnancy testing as
well as in the detection and management of trophoblastic and
nontrophoblastic neoplasms.

Howanitz and Howanitz (1979)

reported that adenocarcinoma of the stomach, ovary, and
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pancreas as well as hepatomas were the tumors most commonly
associated with ectopic hCG prcduction and recommended
quantitative determinations of beta-hCG for monitoring
therapy.
In a review by Lau et al. (1976), Ascheim and Zondek
were credited with developing the first recognized assay
for hCG in 1928.

Ascheim and Zondek's bioassay used imma-

ture female mice and was followed by numerous other assays
which used rats, mice, rabbits and frogs.

It was not

until 1968 that Wide and Gemzell introduced the first
immunological assay for hCG (Lau, 1976).
Present assays for hCG are predominantly immunological
in nature and may be divided into two major classes:

(1)

agglutination or aggregation assays and (2) ligand assays
using either an enzymatic or radioactive label or detection
system.

The agglutination assays for hCG involve either the

agglutination of particles coated with antibody to hCG or
the neutralization of antibody to hCG preventing antibody
binding to hCG coated particles.

This type of assay, while

easy to perform, lacks sensitivity and is only semiquantitative.
Ligand assays may be divided into isotopic, nonisotopic and the hybrid radioenyzmatic assays.

All three

types are sensitive to low concentrations of analyte,but
this sensitivity in itself may reveal problems such as a
lack of specificity, a difficulty particularly prevalent in
receptor based assays.

Other problems with ligand assays
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may be caused by using radioactive materials.

The use of

radioisotopes results in short shelf life, often measured in
weeks, as well as requiring special procedures for handling
radioactive materials and wastes.

Radioassays also require

the use of expensive equipment such as gamma or scintillation
spectrometers.

Enzyme immunoassay techniques such as

enzyme-linked immunosorbent assay (ELISA) or enzyme multiplied immunometric technique (EMIT) have been proposed as
replacements for radioisotopic procedures.
This research was initiated with two objectives:
(1) to investigate the binding of hCG to polystyrene and
(2) to evaluate the applicability of radioassay equations
to enzyme immunoassays.

REVIEW OF LITERATURE

Human Chorionic Gonadotropin
Human chorionic gonadotropin is a glycoprotein hormone
secreted by the Langhans' cells of the placental chorionic
villi.

The biological activities of hCG and hLH are the

same, stimulating the corpus luteum to secrete progesterone
(Daughaday, 1974).

There are conflicting reports as to the

role of hCG in immunosuppression.

Han (1974) reported that

hCG suppressed lymphocyte response, and Schiff et al. (1975)
reported that hCG levels found in maternal serum were too
low to inhibit lymphocyte response in vitro.
Human chorionic gonadotropin levels are detectable in
the serum 8-10 d after implantation of the embryo into the
uterine wall and double every 1.4-2.1 d.

The hCG levels

peak after 6-8 wk gestation with levels from 40,000 to over
200,000 mIU/ml.

After peaking, hCG levels decline and then

plateau at levels of 1,000-10,000 mIU/ml.

At 36-38 wk hCG

levels rise to give a second peak (Goldstein and Kasasa,
1975).

Kadar et al. (1981) recommended serial determination

of hCG levels in the maternal serum to detect at-risk
pregnancies and to alert the physician to abnormalities
such as multiple gestation, spontaneous abortion, or
trophoblastic disease.
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Composition of hCG
Human chorionic gonadotropin is composed of an alpha
subunit with a molecular weight of 13,000 and a beta subunit
with a molecular weight of 28,000.

It has a high degree of

homology with the glycoprotein hormone hLH.

When compared to

hLH, the alpha subunit of hCG is missing a segment of three
amino acids and has an inversion of two amino acids (Bhagavan,
1978).

While 80% of the beta chain of hCG is identical to

hLH, hCG possesses 28 additional amino acids attached to the
carboxyl terminal.

The beta subunit of hCG is composed of

approximately 33% carbohydrate, predominantly sialic acid
and n-acetylglucosamine (Ghai et al., 1980)
Immunologic Properties
Detection of low levels of hCG requires that hLH interference be eliminated.

Antibodies developed against the

alpha subunit of hCG showed parallel dose-response curves
when tested using hLH (Vaitukaitis and Ross, 1972) thus showing that a beta subunit specific antibody was required.

Ghai

et al. (1980) showed that the carbohydrate portion of the
beta subunit of hCG was not responsible for immunological
specificity and that there were probably two types of determinants present, those which were specific for the beta subunit of hCG and those determinants also shared by hLH.
Panadian et al. (1980) investigated the usefulness of
several chemical modifications of the beta subunit of hCG
for developing antisera which had no cross-reactivity with
hLH.

They found that during the preparation of the antigen,
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each step must be monitored in order to prevent contamination
of the antigen with concurrent loss of specificity.

Attempts

to develop antisera to the unique carboxy-terminal peptide
residue of hCG have met with limited success (Louvet et al.,
1974; Matsuura et al., 1979).

Assay Design
Enzyme immunoassays (EIA) are an outgrowth of developments in a number of different fields such as enzymology,
biochemistry and immunology.

Several reviews of enzyme-

immunoassay procedures and principles have been published
(Wisdom, 1976; Voller et al., 1979).

Most EIA assays devel-

oped have been designed mainly by empirical means, although
several investigators have characterized some of the principles upon which the assays are based (Lethonen and Viljanen,
1980; Pain and Surolia, 1979; Cantarero et al., 1980).

Solid Phase Adsorption and Supports
Several authors have reviewed the use of solid phase
supports in immunoassay design.

Leiva (1977) compared var-

ious separation techniques used in ligand assays.

He con-

cluded that the mode of separation of the bound and free
complexes determined the equipment required, the speed and
sensitivity of the assay as well as the maximum number of
tests which could be performed at one time.

Smith and Gehle

(1980) argued for the use of solid phases and listed some of
the support material which had been used in either EIA or RIA.
They stated that while a finely ground solid phase had more
surface area, the separation time required supported the use

7

of a single-piece solid phase.
Cantarero et al. (1980) showed that the binding of
proteins to polystyrene was dependent on a number of factors
such as surface area, concentration of the protein and its
proportion to the total protein level, time and temperature.
Ionic charge did not appear to play a role in protein/polystyrene binding, and the upper limit of protein binding was
correlated to the surface area and the Stokes radii of the
protein--the upper limit being a layer of protein one molecule thick.

Types of Assays
Ekins (1981) discussed the advantages and disadvantages
of several types of immunoassays and labeling systems and
divided the assays into two main groups.

Type I assays are

thcEe procedures in which there is excess antibody present,
and Type II assays are those in which there is excess
analyte.
Type I assays are based on the binding of analyte to a
large excess of antibody followed by detection of the bound
analyte.

Practical applications of this technique have been

in the form of sandwich assays using either radio-labeled
(Shimizu et al., 1982; Wang et al., 1981) or enzyme-labeled
antibody (Voller et al., 1976).

The theoretical sensitivity

of this type of assay approaches one molecule as the antibody
concentration reaches infinity.

While highly purified anti-

gen is not required for Type I assays, nonspecific binding
interactions between antibodies and steric inhibition
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requires that the antibodies have high affinity and
specificity.
Type II assays are generally based on competition between labeled and unlabeled analyte for a limited number of
binding sites.

Classical radioimmunoassay procedures are

examples of this form of assay (Yalow and Berson, 1971).

In

Type II assays, the antibody used must have the same affinity
for both the labeled and unlabeled antigen, the labeled antigen must not be contaminated with potentially cross-reacting
compounds, and the reaction conditions must be carefully controlled (Bolton, 1981).

The sensitivity of Type II assays is

determined by the minimum detectable signal from the labeled
antigen and the affinity constant of the antibody used.

As

antibody concentration approaches zero, Type II assay sensitivity reaches its maximum.
Elkins (1981) concluded that Type I assays are capable
of detecting much lower levels of analyte than Type II
assays.

The Type II assays are, however, less susceptible to

cross-reacting antigens.
Yorde et al. (1976) introduced a new method for immunoassay, CELIA, or competitive enzyme-linked immunoassay.
CELIA involves competition between a solid-phase antigen and
soluble antigen for a fixed number of antibody binding sites.
The amount of antibody bound to the solid phase antigen is
then quantitated and a binding curve inversely proportional
to the free antigen concentration is developed.

This type

of assay used a variation of the Type II assay substituting
the bound antigen for the labeled analyte and detected the
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immobilized antibody through Type I (saturation) techniques.
Yorde et al. (1976) demonstrated the principles of CELIA in
an assay for hCG which had a sensitivity of 1,000 mIU/m1 and
was not specific for the beta subunit.

The assay used hCG

covalently linked to Sepharose particles and three different
antibodies.
Tomoda et al. (1980) developed a sequential solid-phase
assay for hCG using antibody coated silicone rods and hCG
labeled with beta-D-galactosidase from Escherichia coli in a
modified Type II assay.

This assay was sensitive to 0.5

mIU/m1 but not specific for beta-hCG.

Another Type II assay

for hCG was that of Joshi et al. (1981) in which the enzyme
used was penicillinase conjugated to hCG.

Joshi's assay had

a range of 200-1000 mIU/ml, but again was not specific for the
beta subunit of hCG.

Enzyme-Antibody Conjugates
Schick and Singer (1961) reported the coupling of
ferritin and antibody and the use of this conjugate in
electron microscopy.

Avrameas (1969) used gluteraldehyde to

couple the enzyme peroxidase to antibody for use in immunohistochemistry.

Since that time a number of different en-

zymes and techniques have been used (Avrameas et al., 1978).

Staphylococcal Protein A
Staphylococcal Protein A (SPA) is a 42,000-molecular
weight lectin found in the cell wall of certain strains of
Staphylococcus aureus.

SPA has a high affinity for the Fc

portion of mammalian IgG molecules and has been used in a
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e,
number of assays to detect antibody (Langone, 1978; Langon
a,
1980; Engvall, 1979; Notani et al., 1979; Pain and Suroli
1979).

Langone (1978) reported that SPA had a very high

pigs,
affinity for antibodies from rabbits, humans and guinea
but showed only one-thousandth the affinity for mouse IgG.

Monoclonal Antibodies
One of the major problems in the area of immunoassays
has been the inability to produce consistently high-titer
ties
antibodies with suitable specificity in reasonable quanti
for commercial use.

Antisera produced by conventional means

dies of
are heterogenous in nature, consisting of many antibo
differing affinities and specificities.

Attempts to improve

and
antisera specificity by using highly purified antigens
various immunization techniques have been made.

Such methods,

imcombined with affinity chromatography techniques have
y of
proved specificity to some degree; however, the qualit
ncrasies
the antisera produced is still subject to the idiosy
of the individual animal used.
Kohler and Milstein (1975) developed a technique for
ing
the production and continous culture of antibody-secret
cells which the authors referred to as hybridomas.

A hybri-

doma is produced by the fusion of an antibody-producing
an
mouse spleen cell and a plasmacytoma cell forming
immortal antibody-producing cell line.

Since a single B

lymphocyte will produce antibody to only one antigenic
determinant, the ability to grow large quantities of a
of
particular clone enables the production of large quantities

A
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pure antibody of easily definable affinity and specificity.
By conducting a properly designed screening procedure, it is
possible to produce highly specific antibodies to antigenic
determinants using very impure antigens such as crude cell
preparations (Brown et al., 1981).

MATERIALS AND METHODS

Chemicals
Antibody to beta-hCG was obtained from Miles Scientific,
Division of Miles Laboratories (stock number 63-104).

Tween

20, Staphylococcal Protein A-Peroxidase conjugate, and
Sigmacote were obtained from Sigma Chemical Company.
125I-1iCG was specially prepared without additional protein by
Cambridge Radionuclear Incorporated.

Alkaline Phosphatase

anti-beta-hCG antibody was a gift of Hybritech Incorporated
and hCG (Pregnyl) was purchased from Organon Pharmaceutical.
Polystyrene beads and ortho-phenylenediamine (OPD) substrate
were obtained from Abbott Laboratories.
All buffers were prepared with reagent grade chemicals
and the pH determined using an Orion 601A analyser.

Proposed Method
The proposed assay for hCG was a modified version of
Yorde et al. (1976).

The modifications consisted of the use

of a 0.25-in diameter polystyrene bead for the solid phase
and the detection of the bound antibody through the use of
enzyme-labeled Staphylococcal Protein A.
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Adsorption of hCG to Polystyrene Beads
All glassware was siliconized to minimize protein
absorption to glass.

This was accomplished by coating all

internal surfaces of vessels with Sigmacote for approximately 45 sec, draining, and allowing tc air-dry in an
inverted position overnight.

Efficacy of treatment was

checked by observing the nonwetting properties of the coated
tubes using water.
Stock hCG was reconstituted with supplied buffer to a
concentration of 1,000,000 mIU/ml.

One milliliter of stock

hCG was then diluted to a working concentration of 1,000
mIU/ml in 0.06 M carbonate buffer, pH 9.6.

Dilutions of the

working hCG were made to give concentrations of 100, 200, 400,
600, 800 and 1,000 mIU/ml.

Three-milliliter aliquots of the

diluted hCG solutions were placed into three sets of six test
tubes (12 x 75 mm).

After addition of three polystyrene

beads to each tube, one set each was incubated at 3 C, 25 C,
and 37 C for 16 h.
After incubation, the beads were thrice washed with 5-ml
aliquots of phosphate buffered saline with Tween 20
(PBS/Tween) using a multiwell washing assembly (PentawashAbbott).

PBS/Tween was made up of 0.9 g of NaC1, 2.0 g of

KH2PO4, 2.9 g of Na2HPO4:12H20, 0.2 g of KCI, and 0.5 ml of
Tween 20 per liter of distilled water.
After washing, the beads were placed into trays and
incubated with alkaline phosphatase anti-beta-hCG conjugate
(diluted 1:20 with PBS/Tween) for 90 min at 37 C.

The

beads were again washed with PBS/Tween and transferred to
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12 x 75 mm cuvettes.

Two-tenths milliliter of p-nitrophenol

phosphate substrate was added to each tube and allowed to
incubate for 15 min at room temperature.

The addition of

2.0 ml of quenching reagent (0.2M EDTA) stopped the reaction
and the absorbance of the solutions was determined using a
Perkin Elmer Jr II Model 6/20 spectrophotometer.

Quantitative Characterization of Binding
One microcurie of 125I-hCG (SA=169 pCiAug) was added to
1,000 mIU of hCG to give a specific activity of 1000 mIU/pCi/ml.

Serial dilutions of the stock radiolabeled hCG were then

made to give concentrations ranging from 0.98-250 mIU.
Aliquots of 0.5 ml were then added to labeled 12 x 75 mm
polypropylene tubes and two polystyrene beads were added to
each tube.

Following incubation at 37 C overnight, the beads

were then washed with PBS/Tween and counted for 1 min in a
Packard 5110 gamma counter with the window set for 1251.

The

counter had an efficiency of 61%.
One microcurie was added to 16,500 mIU of hCG to give a
specific activity of 16,500 mIU/pCi/ml.

Serial dilutions of

the labeled hCG were made in the range of 2-412.5 mIU/m1
using carbonate buffer.

One bead was placed into each tube

and incubated overnight at 37 C.

The beads were then washed

as previously described and counted.

The activity bound to

the bead was then corrected for decay and counter efficiency
and converted to hCG concentration.
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Staphylococcal Protein A-Enzyme Conjugate
Staphylococcal Protein A-Enzyme conjugate (SPA-E) was
reconstituted with 50% PBS/Tween and glycerol to a concentration of 250 pg/ml.

Dilutions of the SPA-E stock were made in

PBS/Tween to give concentrations ranging from 2.0 pg/m1-2.0
pg/ml.

One hundred-microliter aliquots of the SPA-E dilutions

were pipetted into cuvettes and 300 pl of OPD substrate added.
OPD substrate was made up of 40 mg of OPD-2HC1 in 100 ml of
0.2 M phosphate-citrate buffer, pH 5.0, and 40 pl of
30% v/v H202.

After 30 min incubation at room temperature in

the dark, the reaction was stopped with the addition of 1.0 ml
of 1N HC1 to all tubes.

The delta absorbance at 492/600 nm

was determined using an Abbott Quantum II analyser.
To determine the working concentration of SPA-E required
to detect maximum binding of antibody, hCG coated beads were
incubated with an excess of mouse anti-beta-hCG antibody for
60 min at 37 C.

The beads were then washed three times and

200 Ail of the SPA-E conjugate dilutions were added.

After 60

min incubation at 37 C, the unbound SPA-E was washed off and
the enzyme activity bound was determined by incubating the
beads with 300 All of OPD substrate as outlined above.

Statistical Analysis
To determine whether or not hCG binding was dependent on
temperature or concentration, statistical analyses were performed on the resulting data.

Pearson's product-moment

correlation, linear regression, and 3-way analysis of variance
were carried out.

Analysis of binding properties was done in

accordance with principles set forth by Adrion (1982), Walker

RESULTS

Temperature and Concentration Effects on Binding
The effects of temperature and concentration on the
binding of hCG to the polystyrene beads are shown in Fig 1.
Each absorbance value represents the average of three beads.
Human chorionic gonadotropin binding increased with increasing temperature and concentration reaching a peak at approximately 600 MIU/ml.

Maximum binding occurred at 37 C, and

this temperature was chosen for the remaining studies.
Preliminary binding studies using radiolabeled hCG were
performed using polypropylene tubes.

A significant amount of

radioactive hCG adsorbed to the polypropylene tubes are illustrated in Table

Calculation of the percent-recovery of

the hCG demonstrated that the percentage of hCG binding was
not related to concentration.

Figure 2 depicts percent-bind-

ing versus initial concentration.
The binding studies were repeated using siliconized
glass tubes and hCG with known specific activity.

Calculation

of hCG bound was accomplished by correcting for the counter
efficiency and isotope decay.
hCG recovered versus hCG added.
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Figure 3 is a graph of mIU of
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Figure 1

Effects of temperature and concentration on the
absorption of hCG to polystyrene beads. Alkaline
phosphatase anti-beta-hCG conjugated antibody was
used to detect bound nCG. The substrate used was
p-nitrophenol phosphate. The reaction was stopped
by the addition of 2.0 ml of 0.2M EDTA and
absorbance readings were made at 405 nm. Each
point represents the average of 3 absorbance
values. Incubation temperatures were 3 C (A),
25 C (0) and 37 C (0).
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Table 1.

Binding of radiolabeled hCG to polystyrene beads
and polypropylene tube. 1251-hCG in 0.06 M
carbonate buffer, pH 9.6, was added to 12 x 75
mm polypropylene tubes containing two polystyrene
beads. Following incubation at 37 C for 16 h
the tubes were counted. The tubes and beads were
then washed with PBS/Tween and counted separately.

hCG
bead

CPM1
added

Bead
1

Bead
2

Tube

0.00

84

86

91

86

0.49

1550

240

253

256

0.98

3017

384

358

482

1.95

5668

653

517

988

3.91

11670

1386

1087

2184

7.81

23233

2857

3500

3141

15.62

46534

6196

7000

4404

31.25

91532

9833

10626

6318

62.50

176224

11844

11963

9106

125.00

350568

12944

15120

13023

All cpm are raw counts
hCG/bead denotes approximate mIU of hCG added per
bead.
cpm added are total counts per minute initially added to
tubes.
Bead 1 and 2 are duplicates.
Tube denotes cpm bound to the polypropylene tube used in
incubation.
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Figure 2.

Percentage of hCG bound to polystyrene beads as a
function of initial concentration. Several runs
are shown. (0) represent initial concentrations
of 2-412 mIU/m1 hCG. (0) are beads which were
run in duplicate. (A) denotes binding of hCG to
polypropylene tube.

2

4
$.4 3
C)

1.0

10.0
mIU/m1 of hCG Added

100.0

500.0
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Figure 3.

Binding linearity as a function of initial hCG
concentration. Exclusion of the outlying point
gives the regression line shown. mIU hCG bound
was equal to 0.327 (mIU hCG added), r=0.997.
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Derivation of Binding Capacity and Affinity Constant
The derivation of the binding capacity (Ab) and the
affinity constant (K) of polystyrene for hCG was done
By

according to the methods set forth by Walker (1977).

plotting counts bound against labeled ligand, the curve
shown in Fig 4 was generated.

Two assumptions must be made:

(J) the amount of ligand bound cannot exceed the amount of
ligand added and (2) an upper limit of binding is set by
saturation of all of the binding sites.

By determining the

slope of the line, the level of maximum binding and the 50%
binding concentration, Ab and K may be calculated.

Binding

capacity (Ab) is equal to the cpm bound at the plateau
(Ab=1.0),and the slope is a line drawn tangent to the curve
at the point where binding (B) is G.

Li is equal to the

amount of hCG added at the point where the slope crosses Ab
(point X in Fig 4), L2 being the hCG concentration at the
level of 0.5 Ab.

Ab and K may be determined through the

equations
Li = 1/K + Ab
L2 = 1/K + 0.5 Ab
Thus, 1/K = 2(L2)

Li and Ab = 2(L1) - 2(L2).

Fig 5 is a plot of the data in Table 1 but has not been
corrected for differences in surface area.

Staphylococcal Protein A Conjugate
Fig 6 is a graph of the delta absorbance of 492/600
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Figure 4.

Derivation of K and Ab. OX is the slope tangent
to the curve at 0 mIU binding. (--) denotes the
plateau or maximum binding.
Ab refers to the
total binding capacity of the bead. Curve is
actual binding data. If Ll is defined as the hCG
concentration where the line OX crosses Ab and
the point at which OX crosses 0.5 Ab as L2, then
K may be determined as 1/(2(L2)-L1) and Ab may be
calculated, Ab=2(L1)-2(L2).
K is the affinity
constant of the polystyrene for hCG.

Figure 5.
Binding curves of logloCPM bound versus logioCPM
added of 1251-hCG to polystyrene beads and polypropylene tube. Bead 1 (o), Bead 2 (0) and polypropylene tube (A).

CO
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Figure 6.

Staphylococcal Protein A-enzyme activity vs.
concentration. Staphylococcal Protein A-enzyme
conjugate in amounts ranging from 10-1000 pg/tube were incubated with 300 pl of OPD substrate for 30 min. The reaction was stopped
with the addition of 1 ml of 1N HC1 to each
tube. The delta absorbance at 492/600 nm was
determined using an Abbott Quantum II photometer.
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nm versus SPA-E concentration.

It was determined that a

minimum of 150 pg of SPA-E was required to be bound to the
solid-phase hCG-antibody complex in order to give an adequate
assay range.

Table 2 indicates the results of incubating

SPA-E conjugate in concentrations of 0.05, 0.5, and 1.0 pg/m1
with antibody-saturated beads.
from 0.121 to 0.684.

Absorbance values ranged

Further studies were carried out by

varying both the antibody and the SPA-E concentration in a
"checker board" titration, the results of which are shown
in Fig 7.

The addition of 100 pl of 0.1% bovine serum

albumin to block nonspecific binding virtually eliminated
enzyme activity (Fig 7).
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Table 2.

Effect of varying the SPA-E concentration while
keeping antibody and hCG levels fixed.
Substrate
used was 300 pl of OPD incubated with bead for 30
min at room temperature.
The reaction was stopped
with 1.0 ml of 1N HC1 and the delta absorbance read
on an Abbott Quantum II analyser.

SPA-E pg/ml

Abs 492/600

0.05

0.142

0.50

0.484

1.00

0.604

Abbreviations:

OPD- ortho-phenylenediamine;
SPA-E- Staphylococcal Protein A-Enzyme
conjugate;
Abs 492/600- The difference in the absorbance of the reaction mixture at 492
nm and 600 nm.
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Figure 7.

Absorbance readings for various SPA-E and antibody
concentrations.
hCG concentration was kept constant. SPA-E concentrations were 0.25 (0), 0.5
(0), 1.0 (A) and 2.0 (0) pg/ml. (a) denotes
beads incubated with SPA-E in the absence of
antibody. (M) indicates antibody coated beads
incubated with 2.0 jig/ml SPA-E and 100 pl of
0.1% bovine serum albumin.

500

1000

2000

Dilution of Antisera

DISCUSSION

The results of the temperature studies (Fig 1 and
Table 3) indicated that the binding of hCG to polystyrene
was both temperature and concentration dependent.

The split

plot analysis of variance showed that there were significant
differences in the absorbance readings between temperature
and concentration, between temperature and binding, and between concentration and binding.

The decreased absorbance

level seen at 800 mIU/m1 in Fig I cannot be easily explained.
Possible explanations such as insufficient antibody conjugate being present to saturate all of the hCG binding
sites may be ruled out because of the much higher absorbance
levels seen at 1000 mIU/ml.

Steric inhibition of binding by

the antibody does not appear to be the cause of the decreased
readings.

The decreases in absorbance should have reached

the same level since the inhibition occurred at the same
concentration of hCG.
Linear regression studies of the radiolabeled hCG
binding studies again showed that there was a significant
correlation between the amount of hCG bound and the initial
concentration.

Regression analysis of the percent hCG bound

to the initial concentration was non-significant.
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Table 3.

Results of 3-way analysis of variance. The
independent variables were temperature (A) and
concentration (B). Absorbance was chosen as the
dependent variable.

df

p(F)

Between Temperatures

2

.001

Between Concentrations

8

.001

24

.001

Source

Between Temperature and
Concentration
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The findings that temperature and initial concentration
play significant roles in the binding of hCG to polystyrene
and that the percentage of binding is independent of concentration are in agreement with studies on other proteins
(Cantarero et al., 1980).
The affinity constant, K, was calculated to be
essentially 0, (-0.5 L/IU, and indicated that the binding
was probably entirely passive.

The binding capacity, Ab,

was determined to be 300 mIU/bead.

Cantarero et al. (1980)

reported an upper limit of approximately 1000 ng of protein
was bound to 6.5 cm 2 of polystyrene.

If the value of 1

ng/mIU hCG (Langone, 1980) is used, a maximum protein binding
capacity of approximately 195 ng/bead was determined after
correcting for the difference in surface area of the 0.25-in
diameter polystyrene beads.

Accounting for the beads

increased surface area due to specularization and
experimental error, the actual and calculated values are
in relative agreement.
By knowing the binding capacity of a specific protein
and lot number of polystyrene, assay design could be
simplified and discrepancies in protein concentrations could
be resolved.

Knowing the amount of protein which could

be bound to a solid-phase allows the calculation of the
minimum amount of support material which could be used in a
specific assay (Adrion (1982); and Halfman (1979)).

By

determining the minimum amount of signal which is acceptable
for a particular assay, the minimum amount of surface
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required for a given sample and assay volume may be determined
through Adrion's methods.

The optimum assay parameters may be

derived from Halfman's analyses.
The failure of the Staphylococcal Protein A conjugate to
bind to the monoclonal mouse IgG may be due to several reasons:

(1) the low affinity of SPA for murine IgG as reported

by Langone (1980), (2) the murine antibody is of a subclass
for which SPA has no affinity, and (3) the all or none charac
teristics of monoclonal antibodies.

If, by definition, a

monoclonal antibody is specific for only one antigenic determinant, there will in all probability be only one antibody
molecule binding to the antigen.

The likelyhood of multiple

identical binding sites on a protein is improbable.

Thus,

because of monovalency, the amount of antibody bound is
greatly decreased when compared to conventional polyvalent
antisera.

Increasing the detection limits of the SPA-E con-

jugate, either through the use of chemiluminescent or flourimetric techniques, may compensate for the apparent lack of
SPA-murine IgG interaction if the problem is due to low
affinity; otherwise, antisera from other sources will be required.

Pain and Surolia (1979) and Langone (1978) developed

assays for hCG using SPA as an indicating system; however,
both used rabbit antisera.

SUMMARY

1.

The binding of hCG to polystyrene beads was

temperature and concentration dependent.

Increasing either

the incubation temperature or the initial concentration of
hCG increased the amount of hCG bound to the polystyrene
bead.
2.

The percentage of hCG bound to polystyrene was

independent of the hCG concentration.
3.

The affinity constant, K, of polystyrene for hCG

was essentially 0 and signified that the protein-polymer
interaction was probably passive.
4.

The binding capacity, Ab, of the polystyrene beads

used was 300 mIU of hCG/bead.

This value was in agreement

with published reports for other proteins.
5.

If monoclonal antibodies are to be employed in an

assay then consideration should be given to the applicability
of the indicator system proposed.
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